# A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

> **NCT01891305** · PHASE2 · COMPLETED · sponsor: **Viamet** · enrollment: 50 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** VT-1161
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01891305
- **Lead sponsor:** Viamet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891305, "A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01891305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*